Market Introduction
Drug delivery is an engineered technology that is implemented in medical devices to inject drugs or chemicals into the body. These technologies are used to enhance efficacy, drug absorption, and recovery rate. A few types of the drug delivery systems available in the market include transmucosal, oral, pulmonary, injectable, topical, nasal, implantable, and ocular. Drug delivery systems are primarily used to control the rate of drug release or targeted delivery of various therapeutic agents to treat multiple diseases or improve the health of the patients.
Market Overview and Dynamics
The North America pharmaceutical drug delivery market is expected to reach US$ 9,36,148.9 Mn by 2027 from US$ 5,60,491.5 Mn in 2019. The market is anticipated to grow at a CAGR of 6.8% during 2020–2027. Increasing prevalence of chronic diseases is a prime factor driving the market growth. However, the high cost associated with drug delivery device development restrains the market growth.
Key Market Segments
In terms of the route of administration, the injectable drug delivery segment accounted for the largest share of the North American pharmaceutical drug delivery market in 2018. In terms of application, the cancer segment held the largest market share of the market in 2019. In terms of end users, the hospitals segment held the most significant share of the market in 2018.
Major Sources and Companies Listed
A few of the major primary and secondary sources referred to while building this report on the North America pharmaceutical drug delivery market are the Centers For Disease Control And Prevention (CDC), Food and Drug Administration (FDA), Ministry of Health and Prevention (MoHAP), Ministry of Health and Family Welfare (MoHFW), and American Cancer Society (ACS).
Reasons to buy report
NORTH AMERICA PHARMACEUTICAL DRUG DELIVERY MARKET SEGMENTATION
By Route of Administration
By Application
By Country
Company Profiles
| Report Attribute | Details |
|---|---|
| Market size in 2019 | US$ 5,60,491.5 Million |
| Market Size by 2027 | US$ 9,36,148.9 Million |
| CAGR (2020 - 2027) | 6.8% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By Route of Administration
|
| Regions and Countries Covered |
North America
|
| Market leaders and key company profiles |
|
The North America Pharmaceutical Drug Delivery Market is valued at US$ 5,60,491.5 Million in 2019, it is projected to reach US$ 9,36,148.9 Million by 2027.
As per our report North America Pharmaceutical Drug Delivery Market, the market size is valued at US$ 5,60,491.5 Million in 2019, projecting it to reach US$ 9,36,148.9 Million by 2027. This translates to a CAGR of approximately 6.8% during the forecast period.
The North America Pharmaceutical Drug Delivery Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Pharmaceutical Drug Delivery Market report:
The North America Pharmaceutical Drug Delivery Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Pharmaceutical Drug Delivery Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Pharmaceutical Drug Delivery Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)